Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Here, we demonstrate that elevation of intracellular cyclic AMP (cAMP) in vascular endothelial cells (ECs) by either a direct activator of adenylyl cyclase or endogenous cAMP-mobilizing G protein-coupled receptors inhibited the tyrosine phosphorylation of STAT proteins by an interleukin 6 (IL-6) receptor trans-signaling complex (soluble IL-6Ralpha/IL-6). This was associated with the induction of suppressor of cytokine signaling 3 (SOCS-3), a bona fide inhibitor in vivo of gp130, the signal-transducing component of the IL-6 receptor complex. Attenuation of SOCS-3 induction in either ECs or SOCS-3-null murine embryonic fibroblasts abolished the inhibitory effect of cAMP, whereas inhibition of SHP-2, another negative regulator of gp130, was without effect. Interestingly, the inhibition of STAT phosphorylation and SOCS-3 induction did not require cAMP-dependent protein kinase activity but could be recapitulated upon selective activation of the alternative cAMP sensor Epac, a guanine nucleotide exchange factor for Rap1. Consistent with this hypothesis, small interfering RNA-mediated knockdown of Epac1 was sufficient to attenuate both cAMP-mediated SOCS-3 induction and inhibition of STAT phosphorylation, suggesting that Epac activation is both necessary and sufficient to observe these effects. Together, these data argue for the existence of a novel cAMP/Epac/Rap1/SOCS-3 pathway for limiting IL-6 receptor signaling in ECs and illuminate a new mechanism by which cAMP may mediate its potent anti-inflammatory effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 7×
“Responsiveness to IL-6 requires two components: an IL-6 -receptor (IL-6R ) which binds the cytokine with high affinity, and gp130, which cannot bind IL-6 directly but can interact with IL-6-bound IL-6R to transduce an intracellular signal (19).”
BackgroundInfluentialThe cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 1×
“tors), CGS21680 (A2A adenosine receptor [A2AAR]) and MSH (melanocortin receptor 1), each of which are known to activate adenylyl cyclase and elevate cAMP (11, 14, 33, 44) (Fig.”
BackgroundSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904 · cited 2×
“Further investigation will be required to identify the steps linking ERK activation to the accumulation of SOCS-3 transcript and to determine any significance of the Epac/ SOCS-3 pathway in regulating the activity of other SOCS-3 binding partners, such as IRS1 (38, 49), that play critical roles in EC function in disea…”
BackgroundSOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771 · cited 1×
“A role for SOCS-3 in specifically terminating gp130 and Ob-Rb signaling has been demonstrated by several observations, including the unrestricted agonist-stimulated activation of STAT3 seen in macrophages, hepatocytes, and neurons from cell-specific conditional SOCS-3-deficient mice (8, 32, 56).”
BackgroundMori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Nature Medicine · doi:10.1038/nm1071 · Cited by 651 · cited 1×
“A role for SOCS-3 in specifically terminating gp130 and Ob-Rb signaling has been demonstrated by several observations, including the unrestricted agonist-stimulated activation of STAT3 seen in macrophages, hepatocytes, and neurons from cell-specific conditional SOCS-3-deficient mice (8, 32, 56).”
BackgroundInhibitors of Cytokine Signal Transduction
Wormald, S., & Hilton, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300030200 · Cited by 440 · cited 7×
“SOCS-3 terminates signaling by binding to JAK-phosphorylated receptors via its SH2 domain and interacting with and inhibiting adjacent JAKs via its “kinase inhibitory region,” thereby preventing the recruitment and Tyr phosphorylation of STATs (41).”
BackgroundInfluentialSasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398 · cited 1×
“SOCS-3 terminates signaling by binding to JAK-phosphorylated receptors via its SH2 domain and interacting with and inhibiting adjacent JAKs via its “kinase inhibitory region,” thereby preventing the recruitment and Tyr phosphorylation of STATs ( 41 ).”
BackgroundSchmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., & Schaper, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12848 · Cited by 388 · cited 1×
“SOCS-3 can also potentially competitively block receptor recruitment of SHP-2 to Tyr759 of gp130, thus inhibiting ERK activation (43).”
BackgroundThe SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010074200 · Cited by 311 · cited 1×
“In addition, the C-terminal “SOCS box” domain can target SH2 domain-bound partners for proteasomal degradation by directing interaction with an elongin B/C-Cul5-Rbx1 complex to form an E3 ubiquitin ligase (23, 38).”
BackgroundKang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L., Schwede, F., Genieser, H.-G., & Holz, G. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211682200 · Cited by 298 · cited 1×
“These include positive regulation of integrin-mediated cell adhesion (11, 17), stimulation of insulin secretion via activation of ryanodine-sensitive calcium channels, and control of vesicle exocytosis (20, 24 ).”
BackgroundEndothelial inflammation in insulin resistance
SJOHOLM, A., & NYSTROM, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70804-7 · Cited by 278 · cited 1×
“Further investigation will be required to identify the steps linking ERK activation to the accumulation of SOCS-3 transcript and to determine any significance of the Epac/ SOCS-3 pathway in regulating the activity of other SOCS-3 binding partners, such as IRS1 (38, 49), that play critical roles in EC function in disea…”
BackgroundForskolin as a Tool for Examining Adenylyl Cyclase Expression, Regulation, and G Protein Signaling
Insel, P. A., & Ostrom, R. S. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1023684503883 · Cited by 277
Cited by
Epac: Defining a New Mechanism for cAMP Action
Gloerich, M., & Bos, J. L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105714 · Cited by 473
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
Regulating gene transcription in response to cyclic AMP elevation
Sands, W. A., & Palmer, T. M. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.005 · Cited by 326
Self-citationRegulation of the immune response and inflammation by histamine and histamine receptors
O’Mahony, L., Akdis, M., & Akdis, C. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.051 · Cited by 313
Interleukin-6 signalling: More than Jaks and STATs
Eulenfeld, R., Dittrich, A., Khouri, C., Müller, P. J., Mütze, B., Wolf, A., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.010 · Cited by 171
Metadata
- Authors
- Sands, W. A., Woolson, H. D., Milne, G. R., Rutherford, C., & Palmer, T. M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-09-01
- Volume
- 26
- Issue
- 17
- Pages
- 6333-6346
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2153618088
- Cited by
- 156
- References
- 13
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.